pharmaceutical industry

6:30 am
Mon January 12, 2015

Perrigo Plans Continued Growth

Company headquarters are now based in Ireland
No longer based in Michigan, Perrigo keeps a strong base in West Michigan and continues to hire new employees in the state
6:30 am
Thu November 20, 2014

Zoetis to Buy Animal Health Assets of Abbot Labratories

Deal is to be completed in the first quarter of 2015
  • Source: Mlive
  • | Via: Kalamazoo Gazette
KALAMAZOO, MI - Zoetis Inc. has entered a $255 million deal to buy the animal health assets of Abbott Laboratories Inc. The acquisition will expand Zoetis' portfolio of products for pets and expand its diagnostics business as more pets are being treated for serious illnesses such as cancer and diabetes.
6:32 am
Wed July 16, 2014

No Word on Perrigo Seeking a Buyer

The company offered no comment on a report in an Israeli business publication
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI - Shares of Perrigo Co. PLC gained more than 9 percent Monday in heavy trading as investors reacted to a report that the store-brand products maker may be looking for a buyer. Israeli business publication Globes reported that Perrigo has hired an investment bank "to consider its sale through a merger with a major pharmaceutical firm."
7:53 pm
Mon March 17, 2014

Former Upjohn CEO John Zabriskie dies

Zabriske led Upjohn in the mid-1990's and is considered the architect of the merger with Swedish drug giant Pharmacia AB
  • Source: Mlive
  • | Via: Kalamazoo Gazette
KALAMAZOO, MI -- John L. Zabriskie Jr., former chairman and chief executive officer of The Upjohn Co., died Thursday at his home in Boulder, Colo., after a bout with throat cancer. He was 74. Zabriskie was chairman and CEO of The Upjohn Co.
8:07 pm
Mon March 3, 2014

Perrigo Acquires New Products to Sell Overseas

The products are expected to generate at least $20-million in annual revenue
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI -- Perrigo Co. is expanding its activities overseas with the acquisition of a collection of over-the-counter products sold in Australia and New Zealand and with transactions that modify its involvement with a neuropsychiatric drug being developed in Ireland.